US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BlossomHill Therapeutics

26.22

+4.0518.27%

Volume:128.05K

Turnover:3.14M

Market Cap:803.48M

PE:-10.73

High:26.47

Open:22.34

Low:22.01

Close:22.17

52wk High:26.47

52wk Low:15.25

Shares:30.64M

Float Shares:9.38M

Volume Ratio:1.23

T/O Rate:1.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4440

EPS(LYR):-24.8342

ROE:--

ROA:--

PB:-5.28

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BlossomHill: Buy Rating Reiterated as BH-30643 Data Strengthen Case for C797S-Focused Path; $32 Price Target Maintained

BlossomHill updates BH-30643 lung cancer trial results

BlossomHill Drug Shows 45% Response Rate in Lung Cancer Trial

MT Newswires Live

BlossomHill Therapeutics announces updated SOLARA trial data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BLSM"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":26.22,"timestamp":1789579779074,"preClose":22.17,"halted":0,"volume":128051,"delay":0,"changeRate":0.18267929634641394,"floatShares":9375000,"shares":30643700,"eps":-2.444,"marketStatus":"Trading","change":4.05,"latestTime":"09-16 13:29:42 EDT","open":22.34,"high":26.47,"low":22.01,"amount":3136840.3770549996,"amplitude":0.201173,"askPrice":26.44,"askSize":1,"bidPrice":25.85,"bidSize":135,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":22.17,"preHourTrading":{"tag":"盘前","latestPrice":20.0003,"preClose":22.17,"latestTime":"07:57 EDT","volume":36,"amount":720.0108,"timestamp":1789559857556,"change":-2.1697,"changeRate":-0.097866,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":22,"preClose":22.17,"latestTime":"19:31 EDT","volume":1634,"amount":35973.65,"timestamp":1789515082647,"change":-0.17,"changeRate":-0.007668,"amplitude":0.007668},"volumeRatio":1.227871},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":1.227871,"shares":30643700,"dividePrice":0,"high":26.47,"amplitude":0.201173,"preClose":22.17,"low":22.01,"week52Low":15.25,"pbRate":"-5.28","week52High":26.47,"institutionHeld":0,"latestPrice":26.22,"committee":0.985294,"eps":-2.444,"divideRate":0,"volume":128051,"delay":0,"ttmEps":-2.444,"open":22.34,"prevYearClose":16,"prevWeekClose":20.86,"prevMonthClose":18.3,"prevQuarterClose":16,"fiveDayClose":22,"twentyDayClose":16.1,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-09-15","current":-10.728314,"percent":0.111111,"low":-9.884773,"twenty":-8.847584,"median":-7.505185,"eighty":-6.922359,"high":-2.788792,"avg":-7.707014,"sd":1.365212,"marketCap":666193168},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828},{"date":"2026-08-28","current":-8.535478,"twenty":-7.10945,"median":-6.974951,"eighty":-6.897356,"marketCap":606744468},{"date":"2026-09-04","current":-8.630317,"twenty":-8.140605,"median":-7.054702,"eighty":-6.899943,"marketCap":613486073},{"date":"2026-09-11","current":-9.272633,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"marketCap":659145126},{"date":"2026-09-15","current":-9.371783,"twenty":-8.847584,"median":-7.505185,"eighty":-6.922359,"marketCap":666193168}],"updateTime":1789579782481},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667462944","title":"BlossomHill: Buy Rating Reiterated as BH-30643 Data Strengthen Case for C797S-Focused Path; $32 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462944","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462944?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:35","pubTimestamp":1789493756,"startTime":"0","endTime":"0","summary":"In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on BlossomHill Therapeutics, Inc., with a price target of $32....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/blossomhill-buy-rating-reiterated-as-bh-30643-data-strengthen-case-for-c797s-focused-path-32-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/blossomhill-buy-rating-reiterated-as-bh-30643-data-strengthen-case-for-c797s-focused-path-32-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664478","title":"BlossomHill updates BH-30643 lung cancer trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664478","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664478?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:57","pubTimestamp":1789473452,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics, Inc. ( ($BLSM) ) has issued an announcement. On September 15, 2026, BlossomHill Therapeutics reported updated results fro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/blossomhill-updates-bh-30643-lung-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/blossomhill-updates-bh-30643-lung-cancer-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667443426","title":"BlossomHill Drug Shows 45% Response Rate in Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667443426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667443426?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:42","pubTimestamp":1789472523,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics  said Tuesday that updated data from the phase 1/2 SOLARA trial of BH-30643 showed a 45% objective response rate and an 88% disease control rate in patients with EGFR C797S-positive non-small cell lung cancer following prior EGFR inhibitor treatment.Among 40 patients, 18 achieved a confirmed or ongoing unconfirmed partial response, while 25 remained on treatment at a median follow-up of 6.9 months, the company said.Among 174 patients treated at expansion doses of 40 mg, 50 mg or 60 mg twice daily, treatment-related dose reductions and discontinuations occurred in 9% and 3% of patients, respectively, BlossomHill said.BlossomHill plans to initiate a global phase 2 study targeting EGFR C797S-positive NSCLC in Q1 2027.Shares of the company were 6.7% higher in Tuesday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667864112","title":"BlossomHill Therapeutics announces updated SOLARA trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2667864112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667864112?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470625,"startTime":"0","endTime":"0","summary":"BlossomHill Therapeutics (BLSM) announced updated data from the ongoing Phase 1/2 SOLARA trial of BH-30643 in non-small cell lung cancerm or NSCLC,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-announces-updated-solara-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/blossomhill-therapeutics-announces-updated-solara-trial-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLSM\",params:#limit:6,delay:false,,,undefined,":[]}}